Aegle Therapeutics

Miami, United States

Aegle Therapeutics is a clinical-stage regenerative medicine company that develops novel therapeutics.

$456K raised

Mar 2026

Debt Financing

Biotechnology Clinical Trials Therapeutics

Top Investors

DeepWork Capital Ocean Azul Partners DEFTA Partners New World Angels Tellus BioVentures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aegle Therapeutics

How much funding has Aegle Therapeutics raised?

Aegle Therapeutics has raised $456K in total funding. The most recent round was Debt Financing. The last funding was announced in March 2026.

Who are Aegle Therapeutics's investors?

Aegle Therapeutics's investors include DeepWork Capital, Ocean Azul Partners, DEFTA Partners, New World Angels, Tellus BioVentures.

Where is Aegle Therapeutics headquartered?

Aegle Therapeutics is headquartered in Miami, United States.

What does Aegle Therapeutics do?

Aegle Therapeutics is a clinical-stage regenerative medicine company that develops novel therapeutics.

What stage is Aegle Therapeutics at?

Aegle Therapeutics is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 3, 2026.

MLA

"Aegle Therapeutics — Funding & Investors." VCBacked, March 3, 2026, https://www.vcbacked.co/company/aegle-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2026). Aegle Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/aegle-therapeutics

Wikipedia (cite web)

{{cite web |title=Aegle Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aegle-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 3, 2026.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K